What 7 Analyst Ratings Have To Say About Syndax Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Syndax Pharmaceuticals (NASDAQ:SNDX) has received seven bullish ratings from analysts in the last quarter. The average 12-month price target for the company, according to these analysts, is $36.86, marking a 5.83% increase from the previous average price target of $34.83.
July 25, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Syndax Pharmaceuticals has received seven bullish ratings from analysts in the last quarter, indicating a positive outlook for the company's stock. The average 12-month price target has also increased by 5.83%.
The seven bullish ratings from analysts indicate a positive sentiment towards Syndax Pharmaceuticals. This, coupled with the increase in the average 12-month price target, suggests that the company's stock is expected to perform well in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100